Market Cap 228.82M
Revenue (ttm) 149.50M
Net Income (ttm) -74.62M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -49.91%
Debt to Equity Ratio 0.00
Volume 2,061,900
Avg Vol 1,135,260
Day's Range N/A - N/A
Shares Out 63.56M
Stochastic %K 76%
Beta 1.09
Analysts Sell
Price Target $3.60

Company Profile

MacroGenics, Inc., a clinical-stage biopharmaceutical company, discovers, develops, manufactures, and commercializes antibody-based therapeutics for the treatment of cancer in the United States. The company's product pipeline includes lorigerlimab, a bispecific DART molecule that targets checkpoint inhibitors PD-1 and CTLA-4 for the treatment of mCRPC and docetaxel that is in phase 2 clinical trials, as well as for the treatment of platinum-resistant ovarian cancer and clear cell gynecologic can...

Industry: Biotechnology
Sector: Healthcare
Phone: 301 251 5172
Fax: 301 251 5321
Address:
9704 Medical Center Drive, Rockville, United States
bundy3333
bundy3333 Apr. 11 at 7:15 AM
$MGNX @Budman10 tx, but no source found, no SEC The suspicious time of publication and tripling the share price target together with technical chart situation seems to me like possible try to manipulate the share price by third parties. In total maximal lost on Friday for longies 35 cent (10 percent) since alert 07:53 / 08:00 o'clock .... MGNX revenue 2025 has been dependant of manufacturing for other parties and not sale of own products. It seems not to make sense to triple share price from about 1 to 3,50 USD and AFTER reaching 52 weeks high to triple fair value from 200 to 600 million just by saying, if another pipeline product of a third party might be valued with 156 million, MGNX would be supposed to have 400 million of assets nobody thought about for up to 36 months. B. Riley Securities included! Share price on Monday? I don't have any clue Might go short again there at 4,50 USD or at less than 3,30 USD ? Still thinking, fair value during 2026 less than 2,70 USD. HHTX,
1 · Reply
Budman10
Budman10 Apr. 10 at 10:13 PM
$MGNX up because the ADC market has been depressed and recent acquisition. Way undervalued. Just need some good news to get this to the true next level.
1 · Reply
bundy3333
bundy3333 Apr. 10 at 8:17 PM
$MGNX $BUNDY3333 missing Post #2 Missing
0 · Reply
bundy3333
bundy3333 Apr. 10 at 8:14 PM
$MGNX $BUNDY333 test post tTest
0 · Reply
Danielord
Danielord Apr. 10 at 6:15 PM
$MGNX very
0 · Reply
anachartanalyst
anachartanalyst Apr. 10 at 6:02 PM
$MGNX https://anachart.com/wp-content/uploads/ana_temp/1775844113_soc-img.jpg
0 · Reply
Tain0os
Tain0os Apr. 10 at 3:53 PM
$MGNX added long.
0 · Reply
Danielord
Danielord Apr. 10 at 3:42 PM
$MGNX we need volume
0 · Reply
StocktwitsNews
StocktwitsNews Apr. 10 at 2:09 PM
MGNX Stock Hits 16-Month High, But This Analyst Sees Another 140% Potential Upside $MGNX $GILD https://stocktwits.com/news/equity/markets/mgnx-stock-hits-16-month-high-but-this-analyst-sees-another-140-potential-upside/cZJ0hNZRIt1
1 · Reply
Budman10
Budman10 Apr. 10 at 1:38 PM
$MGNX JPMorgan Chase & Co. Increases Stake in MacroGenics, Inc. $MGNX Written by MarketBeat April 10, 2026
0 · Reply
Latest News on MGNX
MacroGenics to Participate in Upcoming Investor Conferences

Feb 26, 2026, 5:30 PM EST - 6 weeks ago

MacroGenics to Participate in Upcoming Investor Conferences


MacroGenics to Participate in Upcoming Investor Conference

May 1, 2025, 4:30 PM EDT - 1 year ago

MacroGenics to Participate in Upcoming Investor Conference


MacroGenics Announces Leadership Transition

Oct 30, 2024, 7:30 AM EDT - 1 year ago

MacroGenics Announces Leadership Transition


bundy3333
bundy3333 Apr. 11 at 7:15 AM
$MGNX @Budman10 tx, but no source found, no SEC The suspicious time of publication and tripling the share price target together with technical chart situation seems to me like possible try to manipulate the share price by third parties. In total maximal lost on Friday for longies 35 cent (10 percent) since alert 07:53 / 08:00 o'clock .... MGNX revenue 2025 has been dependant of manufacturing for other parties and not sale of own products. It seems not to make sense to triple share price from about 1 to 3,50 USD and AFTER reaching 52 weeks high to triple fair value from 200 to 600 million just by saying, if another pipeline product of a third party might be valued with 156 million, MGNX would be supposed to have 400 million of assets nobody thought about for up to 36 months. B. Riley Securities included! Share price on Monday? I don't have any clue Might go short again there at 4,50 USD or at less than 3,30 USD ? Still thinking, fair value during 2026 less than 2,70 USD. HHTX,
1 · Reply
Budman10
Budman10 Apr. 10 at 10:13 PM
$MGNX up because the ADC market has been depressed and recent acquisition. Way undervalued. Just need some good news to get this to the true next level.
1 · Reply
bundy3333
bundy3333 Apr. 10 at 8:17 PM
$MGNX $BUNDY3333 missing Post #2 Missing
0 · Reply
bundy3333
bundy3333 Apr. 10 at 8:14 PM
$MGNX $BUNDY333 test post tTest
0 · Reply
Danielord
Danielord Apr. 10 at 6:15 PM
$MGNX very
0 · Reply
anachartanalyst
anachartanalyst Apr. 10 at 6:02 PM
$MGNX https://anachart.com/wp-content/uploads/ana_temp/1775844113_soc-img.jpg
0 · Reply
Tain0os
Tain0os Apr. 10 at 3:53 PM
$MGNX added long.
0 · Reply
Danielord
Danielord Apr. 10 at 3:42 PM
$MGNX we need volume
0 · Reply
StocktwitsNews
StocktwitsNews Apr. 10 at 2:09 PM
MGNX Stock Hits 16-Month High, But This Analyst Sees Another 140% Potential Upside $MGNX $GILD https://stocktwits.com/news/equity/markets/mgnx-stock-hits-16-month-high-but-this-analyst-sees-another-140-potential-upside/cZJ0hNZRIt1
1 · Reply
Budman10
Budman10 Apr. 10 at 1:38 PM
$MGNX JPMorgan Chase & Co. Increases Stake in MacroGenics, Inc. $MGNX Written by MarketBeat April 10, 2026
0 · Reply
topstockalerts
topstockalerts Apr. 10 at 1:29 PM
$MGNX kinda creeping higher but you can feel the strength building
0 · Reply
BZAJDEL
BZAJDEL Apr. 10 at 1:24 PM
$MGNX We fly today!
0 · Reply
PMD777
PMD777 Apr. 10 at 1:21 PM
$MGNX doing some AI digging and they get positive feedback on vobra-duo and it’s instantly $6 but they need to bolster their cash runway with a new partnership to avoid dilution
0 · Reply
Budman10
Budman10 Apr. 10 at 12:52 PM
$MGNX Current report suggests 4 million shares short. Should see some covering today.
0 · Reply
ImKneedeepinit
ImKneedeepinit Apr. 10 at 12:40 PM
$MGNX I put all my money right here with macrogenics.... I'm all in.... Wait n see.... $TPET $MARA Very
0 · Reply
Jkpga
Jkpga Apr. 10 at 12:39 PM
$MGNX 🔥
0 · Reply
topstockalerts
topstockalerts Apr. 10 at 12:10 PM
$MGNX Strong momentum setup shaping up. Buyers are defending these levels and pushing higher. Could see continuation from here.
0 · Reply
DonCorleone77
DonCorleone77 Apr. 10 at 11:21 AM
$MGNX $GILD MacroGenics upgraded to Buy at B. Riley after deal for Tubulus B. Riley upgraded MacroGenics (MGNX) to Buy from Neutral with a $9 price target. Following the Gilead (GILD) deal for Tubulus earlier this week, the firm put together a proprietary valuation framework on emerging next-gen antibody-drug conjugate pipeline and platform companies and views MacroGenics as "uniquely situated within the next-gen ADAM9 TOPO1i ADC space," the analyst tells investors.
2 · Reply
StormForged
StormForged Apr. 10 at 11:04 AM
$MGNX Clinical Pipeline & Drug Development..
0 · Reply
PMD777
PMD777 Apr. 10 at 11:02 AM
$MGNX something is up- looking like they might push it over resistance at $3.50 pm
0 · Reply
bundy3333
bundy3333 Apr. 9 at 9:54 AM
$MGNX Does anybody know, how many of the awaited around 20 additional patients should belong to the group CCGC ? The number could be around zero! Estimated study completion 08/2027 NCT06730347
1 · Reply
focafoca99
focafoca99 Apr. 8 at 11:38 PM
$MGNX said the FDA removed the partial clinical hold on the Phase 2 LINNET study, allowing enrollment to resume under a revised protocol.
0 · Reply